Balanced Budget Accountability Act

Middle-mile broadband infrastructure issues, generally; Spectrum issues, generally, including the FCC's 6 GHz spectrum proposal; Pole attachment issues, generally;

Client expense: $2,920,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Affordable Care Act, Affordability, Behavioral Health, Health Equity, Maternal Health, Surprise Billing, Health IT, Interoperability, Value-Based Care, Health Care Innovation, COVID-19 Commercialization, Telehealth-extending flexibilities, Transparency & PBMs (S. 127, S. 1339, H.R. 3651, H.R. 4507, H.R. 4508, H.R. 4509, H.R. 4527, H.R. 4822, H.R. 5378), Provider Directories, Insulin Affordability (S. 1269, S. 954), Prescription Drugs (S. 6, S. 150, S. 1067, S. 1114, S. 2305)

Client expense: $620,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Middle-mile broadband infrastructure issues, generally; Spectrum issues, generally, including the FCC's 6 GHz spectrum proposal; Pole attachment issues, generally;

Client expense: $2,720,000 · Firm income: Not reported

Affordable Care Act, Behavioral Health, Health Equity, Maternal Health, Implementation of No Surprises Act, Health IT, Interoperability, Value-Based Care, Health Care Innovation, COVID-19 Commercialization, Telehealth-extending flexibilities, Pharmacy Benefit Managers (S. 127, S. 1339), Provider Directories, Insulin Affordability (S. 1269, S. 954), Promoting Access to Treatments and Increasing Extremely Needed Transparency (H.R. 3561), Lower Costs More Transparency Act (H.R. 5378), Prescription Drugs (S. 6, S. 1114, S. 1067, S. 150), Health Care Price Transparency Act of 2023 (H.R. 4822)

Client expense: $570,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Middle-mile broadband infrastructure issues, generally; Spectrum issues, generally, including the FCC's 6 GHz spectrum proposal; Pole attachment issues, generally;

Client expense: $1,890,000 · Firm income: Not reported

Insulin Out of Pocket Charges; Finance PBNM Framework Proposals; S. 150 - Affordable Prescriptions for Patients Act of 2023 A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. John Cornyn (R-TX) S. 127 - Pharmacy Benefit Manager Transparency Act of 2023 A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes. Sponsor: Sen. Maria Cantwell (D-WA) S.1067 - Ensuring Timely Access to Generics Act of 2023 To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1114 - Expanding Access to Low-Cost Generics Act of 2023 To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period. Sponsor: Sen. Smith, Tina [D-MN] S.1269 - INSULIN Act of 2023 To reduce the price of insulin and provide for patient protections with respect to the cost of insulin. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1339 - Pharmacy Benefit Manager Reform Act To provide for increased oversight of entities that provide pharmacy benefit management services on behalf of group health plans and health insurance coverage. Sponsor: Sen. Sanders, Bernard [I-VT] S. 6 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT]

Client expense: $1,580,000 · Firm income: Not reported

Insulin Out of Pocket Charges; S. 150 - Affordable Prescriptions for Patients Act of 2023 Sponsor: Sen. John Comyn (R-TX) S. 127 - Pharmacy Benefit Manager Transparency Act of2023 Sponsor: Sen. Maria Cantwell (D-WA) S. 1067 -- Ensuring Timely Access to Generics Act of 2023 Sponsor: Sen. Maria Dantwell (D-WA) S. 1114 - Expanding Access to Low-Cost Generics Act of 2023 Sponsor: Sen. Shaheen, Jeanne (D-NH) S. 1269 - INSULIN Act of 2023 Sponsor: Sen. Smith, Tina (D-NH) S. 1339 - Pharmacy Benefit Manager Reform Act Sponsor: Sen Sanders, Bernard (I-VT) S. 6 - Biosimilar Red Tape Elimination Act Sponsor: Sen Lee, Mike (R-UT)

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Middle-mile broadband infrastructure issues, generally; Spectrum issues, generally, including the FCC's 6 GHz spectrum proposal; Pole attachment issues, generally;

Client expense: $3,390,000 · Firm income: Not reported